中航沈飛(600760.SH):全資子公司擬吸收合併上海沈飛國際貿易有限公司
格隆匯 6 月 22日丨中航沈飛(600760.SH)公佈,公司全資子公司瀋陽飛機工業(集團)有限公司(“沈飛公司”)擬吸收合併上海沈飛國際貿易有限公司(“上海公司”)。沈飛公司為公司全資子公司,上海公司為沈飛公司全資子公司,吸收合併完成後,上海公司獨立法人資格註銷,其全部資產、債權、債務和業務等由沈飛公司承繼。
公司全資子公司沈飛公司吸收合併全資孫公司上海公司,符合公司的戰略發展和管理需求,有利於縮短管理鏈條、優化資源配置,有利於集中優質資源、聚焦航空主業,不會對公司財務狀況、盈利水平產生重大影響,不會損害公司及全體股東的利益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.